je.st
news
Tag: activity
Eagle Ford sees slight increase in drilling activity
2015-06-13 14:09:10| Oil & Gas - Topix.net
The oil patch is seeing some signs of stabilization in the Eagle Ford and other shale plays across the United States. West Texas Intermediate crude prices were trading around $60 per barrel this week and have held steady at that level for the past four weeks.
Tags: increase
activity
ford
eagle
Notable Friday Option Activity: AAPL, HOT, CSC
2015-06-13 10:54:43| IT Services - Topix.net
We work to find the most relevant and interesting articles about yield stocks to share with Forbes readers. The site is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.
Tags: hot
friday
option
activity
Notable Wednesday Option Activity: PCLN, UPS, CMG
2015-06-04 00:25:31| Trucking - Topix.net
We work to find the most relevant and interesting articles about yield stocks to share with Forbes readers. The site is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.
Tags: option
wednesday
activity
ups
Notable Wednesday Option Activity: PCLN, UPS, CMG
2015-06-03 22:29:09| Air Courier - Topix.net
We work to find the most relevant and interesting articles about yield stocks to share with Forbes readers. The site is a one-stop source for aggregated data on dividend stocks, including features such as a dividend stock screener, a live dividend feed, an ex-div calendar, and a dividend calculator.
Tags: option
wednesday
activity
ups
Findings Presented at 2015 ASCO Annual Meeting Add to Breadth of KEYTRUDA (pembrolizumab) Data; Anti-Tumor Activity Now Demonstrated in 13 Different Tumor Types
2015-06-01 14:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. New Data Presented at ASCO in Multiple, Difficult-to-Treat Cancers, including Small Cell Lung, Esophageal and Ovarian Cancers Registrational Studies for KEYTRUDA Ongoing in Eight Different Tumor Types KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first-time presentation of findings investigating the use of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, in multiple, difficult-to-treat cancers, including advanced small cell lung cancer (SCLC), esophageal cancer and ovarian cancer from the KEYNOTE-028 Phase 1b study. Language: English Contact: MerckMedia:Pamela Eisele, 267-664-0282orClaire Mulhearn, 908-200-1889orInvestors:Joseph Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: add
data
types
presented
Sites : [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] next »